Related Experiment Video

Updated: Mar 4, 2026

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

11.9K

The Rate of Sepsis in a National Pediatric Population, 2006 to 2012

Kristin A Schuller1, Benson S Hsu2,3, Allyson B Thompson4

  • 11 Ohio University, Athens, OH, USA.

Clinical Pediatrics
|April 20, 2017
PubMed

Insights

Pediatric severe sepsis cases are increasing annually in the US. This study found sepsis rates rose significantly from 2006 to 2012, highlighting at-risk populations for targeted interventions.

Area of Science:

  • Pediatric critical care
  • Public health surveillance
  • Epidemiology of infectious diseases

Background:

  • The incidence of pediatric severe sepsis is rising in the United States, with an estimated 6000 additional cases annually.
  • A growing concern for healthcare providers and policymakers due to increasing pediatric sepsis rates.

Purpose of the Study:

  • To determine the trend in pediatric sepsis rates per 100,000 inpatient discharges over time.
  • Identify changes in sepsis incidence among hospitalized children.

Main Methods:

  • Utilized the 2006, 2009, and 2012 Healthcare Cost and Utilization Project Kid's Inpatient Databases.
  • Analyzed large-scale administrative data to track sepsis rates in pediatric populations.

Main Results:

  • Pediatric sepsis rates increased from 92.8 per 100,000 discharges in 2006 to 158.7 per 100,000 in 2012.
  • Infants under one year, children with Medicaid, and those undergoing multiple procedures showed significantly higher sepsis rates.

Conclusions:

  • Identified key demographic factors associated with increased risk for pediatric sepsis.
  • Findings support targeted interventions and policy adjustments to address sepsis in vulnerable pediatric populations.
Abstract

Keywords:
pediatric sepsisrate of sepsissepsis policytrends in sepsis

More Related Videos

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

7.0K
A Data-Driven Approach to Quantifying Immune States in Sepsis07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

559

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
388
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
294
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
340
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
446
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.4K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
457